Thermo Fisher, US8835561023

Thermo Fisher stock heads into the open after a 0.4% loss

Published on 09/10/2026 at 03:19 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS

At the close on September 9, 2026, Thermo Fisher stock slipped about 0.4% on the NYSE, underperforming the S&P 500’s 0.5% decline, as UBS raised its price target to USD 730 and upgraded the shares to Buy.

Aquarellbild eines gläsernen Forschungscampus an einem Fluss mit herbstlichen Bäumen
Aquarellmalerei symbolisiert Thermo Fisher Sci. US8835561023 mit gläsernem Forschungscampus entlang eines ruhigen Flusses im Herbst, Illustration mit AI erstellt.

Thermo Fisher stock closed at USD 598.88 on the NYSE on September 9, 2026, down 0.4% from the prior session. The move lagged the S&P 500, which fell 0.5% to 7,636.36 on the same day, underscoring mild relative weakness against the broader market. On September 9, 2026, UBS upgraded Thermo Fisher to Buy and lifted its price target to USD 730, a call that highlighted confidence in the company’s medium-term growth trajectory and drew investor attention to the shares, as reported by Yahoo Finance.

September 9, 2026 in numbers

Thermo Fisher Scientific Inc. (ISIN US8835561023, NYSE: TMO) closed at USD 598.88 on September 9, 2026, after trading modestly lower through the session, with a decline of approximately 0.4% versus the previous close. Sector data showed Thermo Fisher down 0.37% among major healthcare names, according to a market movers overview from TradingKey, indicating a relatively contained pullback compared with steeper losses in some peers. The same day, the S&P 500 finished at 7,636.36, down 0.5%, per closing figures summarized by WTOP, so Thermo Fisher slightly outperformed the benchmark in percentage terms despite ending in negative territory. UBS’s price target increase to USD 730, up from USD 540, framed the shares as offering upside from the latest close and was echoed in coverage by TipRanks, adding a supportive analyst backdrop even as the stock eased slightly.

Today’s focus for Thermo Fisher

Heading into today’s session on September 10, 2026, investors in Thermo Fisher are set to digest the UBS upgrade and higher price target, which positioned the shares for potential re-rating over time and highlighted expectations of mid-single-digit organic revenue growth in the coming years, as discussed by Yahoo Finance. Broader market sentiment after the S&P 500’s 0.5% drop on September 9, 2026, and ongoing sector moves in healthcare names could also influence Thermo Fisher’s trading tone today, with the stock’s slight underperformance relative to the index in the last session forming the immediate backdrop for price action once the opening bell rings.

Disclaimer...

en | US8835561023 | THERMO FISHER | boerse | 70078320 | bgmi